264 related articles for article (PubMed ID: 25576595)
1. The inducible costimulator augments Tc17 cell responses to self and tumor tissue.
Nelson MH; Kundimi S; Bowers JS; Rogers CE; Huff LW; Schwartz KM; Thyagarajan K; Little EC; Mehrotra S; Cole DJ; Rubinstein MP; Paulos CM
J Immunol; 2015 Feb; 194(4):1737-47. PubMed ID: 25576595
[TBL] [Abstract][Full Text] [Related]
2. Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling.
Bowers JS; Nelson MH; Kundimi S; Bailey SR; Huff LW; Schwartz KM; Cole DJ; Rubinstein MP; Paulos CM
Clin Cancer Res; 2015 Jun; 21(11):2546-57. PubMed ID: 25904754
[TBL] [Abstract][Full Text] [Related]
3. Retrogenic ICOS Expression Increases Differentiation of KLRG-1hiCD127loCD8+ T Cells during Listeria Infection and Diminishes Recall Responses.
Liu D; Burd EM; Coopersmith CM; Ford ML
J Immunol; 2016 Feb; 196(3):1000-12. PubMed ID: 26729800
[TBL] [Abstract][Full Text] [Related]
4. The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells.
Paulos CM; Carpenito C; Plesa G; Suhoski MM; Varela-Rohena A; Golovina TN; Carroll RG; Riley JL; June CH
Sci Transl Med; 2010 Oct; 2(55):55ra78. PubMed ID: 20980695
[TBL] [Abstract][Full Text] [Related]
5. The development of IL-17/IFN-γ-double producing CTLs from Tc17 cells is driven by epigenetic suppression of Socs3 gene promoter.
Satoh T; Tajima M; Wakita D; Kitamura H; Nishimura T
Eur J Immunol; 2012 Sep; 42(9):2329-42. PubMed ID: 22674086
[TBL] [Abstract][Full Text] [Related]
6. Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice.
Garcia-Hernandez Mde L; Hamada H; Reome JB; Misra SK; Tighe MP; Dutton RW
J Immunol; 2010 Apr; 184(8):4215-27. PubMed ID: 20237297
[TBL] [Abstract][Full Text] [Related]
7. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
8. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.
Tajima M; Wakita D; Satoh T; Kitamura H; Nishimura T
Int Immunol; 2011 Dec; 23(12):751-9. PubMed ID: 22039016
[TBL] [Abstract][Full Text] [Related]
9. ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells.
Guedan S; Chen X; Madar A; Carpenito C; McGettigan SE; Frigault MJ; Lee J; Posey AD; Scholler J; Scholler N; Bonneau R; June CH
Blood; 2014 Aug; 124(7):1070-80. PubMed ID: 24986688
[TBL] [Abstract][Full Text] [Related]
10.
Flores-Santibáñez F; Cuadra B; Fernández D; Rosemblatt MV; Núñez S; Cruz P; Gálvez-Cancino F; Cárdenas JC; Lladser A; Rosemblatt M; Bono MR; Sauma D
Front Immunol; 2018; 9():209. PubMed ID: 29472932
[TBL] [Abstract][Full Text] [Related]
11.
Hu X; Majchrzak K; Liu X; Wyatt MM; Spooner CJ; Moisan J; Zou W; Carter LL; Paulos CM
Cancer Res; 2018 Jul; 78(14):3888-3898. PubMed ID: 29769201
[TBL] [Abstract][Full Text] [Related]
12. Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic.
Majchrzak K; Nelson MH; Bailey SR; Bowers JS; Yu XZ; Rubinstein MP; Himes RA; Paulos CM
Cancer Immunol Immunother; 2016 Mar; 65(3):247-59. PubMed ID: 26825102
[TBL] [Abstract][Full Text] [Related]
13. Development of interleukin-17-producing Vγ2+ γδ T cells is reduced by ICOS signaling in the thymus.
Buus TB; Schmidt JD; Bonefeld CM; Geisler C; Lauritsen JP
Oncotarget; 2016 Apr; 7(15):19341-54. PubMed ID: 27235509
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17.
Kondo T; Takata H; Matsuki F; Takiguchi M
J Immunol; 2009 Feb; 182(4):1794-8. PubMed ID: 19201830
[TBL] [Abstract][Full Text] [Related]
15. Inducible costimulator facilitates T-dependent B cell activation by augmenting IL-4 translation.
Gigoux M; Lovato A; Leconte J; Leung J; Sonenberg N; Suh WK
Mol Immunol; 2014 May; 59(1):46-54. PubMed ID: 24486724
[TBL] [Abstract][Full Text] [Related]
16. Tc17 CD8 T cells: functional plasticity and subset diversity.
Yen HR; Harris TJ; Wada S; Grosso JF; Getnet D; Goldberg MV; Liang KL; Bruno TC; Pyle KJ; Chan SL; Anders RA; Trimble CL; Adler AJ; Lin TY; Pardoll DM; Huang CT; Drake CG
J Immunol; 2009 Dec; 183(11):7161-8. PubMed ID: 19917680
[TBL] [Abstract][Full Text] [Related]
17. The Costimulatory Molecule ICOS Regulates Host Th1 and Follicular Th Cell Differentiation in Response to Plasmodium chabaudi chabaudi AS Infection.
Wikenheiser DJ; Ghosh D; Kennedy B; Stumhofer JS
J Immunol; 2016 Jan; 196(2):778-91. PubMed ID: 26667167
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms.
Yu Y; Cho HI; Wang D; Kaosaard K; Anasetti C; Celis E; Yu XZ
J Immunol; 2013 Feb; 190(4):1873-81. PubMed ID: 23315072
[TBL] [Abstract][Full Text] [Related]
19. Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis.
Frey O; Meisel J; Hutloff A; Bonhagen K; Bruns L; Kroczek RA; Morawietz L; Kamradt T
Ann Rheum Dis; 2010 Aug; 69(8):1495-501. PubMed ID: 20498202
[TBL] [Abstract][Full Text] [Related]
20. RORγ Agonists Enhance the Sustained Antitumor Activity through Intrinsic Tc17 Cytotoxicity and Tc1 Recruitment.
Liu X; Zawidzka EM; Li H; Lesch CA; Dunbar J; Bousley D; Zou W; Hu X; Carter LL
Cancer Immunol Res; 2019 Jul; 7(7):1054-1063. PubMed ID: 31064778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
